Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Aïda Amer/Axios
Climate change is going to make us sick. We’ll need prescription drugs to get better. And that’s a business opportunity the pharmaceutical industry is starting to prepare for.
Between the lines: Those companies either declined to estimate the financial impact this increased demand would have, or said it would be minor. Several highlighted partnerships to make certain life-saving drugs available at reduced prices, especially in developing countries.
Driving the news: A non-profit organization called CDP asks companies to identify “risks and opportunities” they’ll face because of climate change, and grades them on their preparations.
- Big pharmaceutical companies foresee similar risks — including physical damage to their facilities, supply-chain disruptions from increasingly powerful storms, and higher costs stemming from new energy regulations.
- They also identified a consistent opportunity: More demand for drugs, thanks to the health effects of climate change.
What they’re saying:
- AbbVie: “Climate change may create a greater need for existing or even new products … higher temperatures and drought conditions are becoming extreme … Our immunology product line could see an increase in sales as a result.”
- Eli Lilly: “These risks may drive an increased demand for ... our diabetes products.”
- Merck: “As the climate changes, there will be expanded markets for products for tropical and weather related diseases including water borne illness.”
- Pfizer: “There could be an increased demand for products related to diseases impacted by climate change.”
The big picture: They’re right. The various effects of climate change — hotter temperatures, severe weather and dirtier air, among them — are expected to exacerbate a host of health problems. including infectious diseases, asthma and other respiratory diseases. And those are ailments we treat with drugs.
- Don’t take my word for it: Here’s information from the CDC, the NIH and the World Health Organization.